Efficacy and safety of rituximab in patients with multiple sclerosis: An observational study...

The efficacy and safety of Anti-CD20 antibody treatments in relapsing multiple sclerosis: A systematic review and network meta-analysis

X Wu, X Tan, J Zhang, Z Wang, W Wu, S Wang, Y Liu… - CNS drugs, 2022 - Springer
Background Several large randomized controlled trials of anti-CD20 antibodies have been
successfully conducted for the treatment of relapsing multiple sclerosis. Despite this, there …
Save Cite Cited by 2 Related articles All 5 versions